e-Drug3D

160

METARAMINOL


INN
METARAMINOL

cas 54-49-9
CLASS

CARDIOVASCULAR
ANTIHYPOTENSIVE
ADRENERGIC ALPHA AGONISTS
SYMPATHOMIMETICS
VASOCONSTRICTOR AGENTS

ROUTE (list)

INJECTION

ATC code

C01CA09

PK parameters

Solubility

FREELY SOLUBLE IN WATER


Target

TARGET ALPHA ADRENERGIC RECEPTOR

DrugCentral

Alpha-1A adrenergic receptor UNIPROT P35348 ADRA1A

Download SDF file 3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol

Formula:
C9H13NO2

Calculated chemical properties:

MW 167.20
NB_atoms 12
XLogP 0.77
PSA 63.721
NB_HD 4
NB_HA 3
fsp3 0.33
Lipinski(0=no;1=yes) 1

FDA
NDA 083363 (pdf not found) INN (METARAMINOL BITARTRATE) METARAMINOL BITARTRATE (ELKINS SINN) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 086418 (pdf not found) INN (METARAMINOL BITARTRATE) METARAMINOL BITARTRATE (GD SEARLE LLC) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 009509 (pdf not found) INN (METARAMINOL BITARTRATE) ARAMINE (MERCK) APPROVAL= AP YEAR= 1954 DISCONTINUED
NDA 080431 (pdf not found) INN (METARAMINOL BITARTRATE) METARAMINOL BITARTRATE (ABRAXIS PHARM) APPROVAL= AP YEAR= 1972 DISCONTINUED
NDA 080722 (pdf not found) INN (METARAMINOL BITARTRATE) METARAMINOL BITARTRATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 1972 DISCONTINUED
NDA 211304 (pdf not found) INN (METARAMINOL BITARTRATE) METARAMINOL BITARTRATE (AZURITY) APPROVAL= AP YEAR= 2021

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL